USFDA concludes inspection at Lupin’s Bioresearch Centre

03 Apr 2019 Evaluate

United States Food and Drug Administration (USFDA) has successfully completed inspection at Lupin’s Bioresearch Centre (LBC) without any observations. This is the 5th successive inspection without any 483 observations, indicating superior quality compliance maintained at this global bioresearch facility.

The company’s Bioresearch Centre (LBC) conducts the in-vivo and in-vitro bioequivalence studies for company in Pune. This inspection also included review of studies done at the center's new site at Lupin Research Park, Pune.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2137.15 -27.90 (-1.29%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×